Susan Hasty, Publisher
Table of Contents . . . June 28th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Bioterrorism Week | Other Publications
Anthrax - CDC collaboration yields new test for anthrax
Anthrax - Public-private partnership extends Dutch-American cooperation in biodefense
Biowarfare - Vaccines for the prevention of diseases caused by potential bioweapons
Policy - To defeat bioterrorism, more international collaboration is needed
Anthrax - NIH supports phase I clinical trial of DNA-based anthrax vaccine
Anthrax Vaccine - B. anthracis antigens for testing anthrax immunity identified
Anti-Infectives - Antimicrobial drug development declining
Biotechnology - BioShield shortcomings subject of industry conference
Biotechnology - Experts warn that gene research could be used for warfare
Bioterrorism - Defense Department starts first responder tech center at Pitt
Business Update - MSSI-TeleScience receives $15M commitment
Collaborations - Dutch biopharma enters collaborative agreement with NMRC
Genomics - Company announces genetic-detection advance in nature biotechnology
Health - FDA certificate to export products to Japan granted for RespAide
Malaria Research - UCSD partners with Peru in NIH grant to battle world's number 2 killer
Outbreaks - Model for disease outbreaks in realistic urban networks developed
Smallpox - Smallpox as biological weapon reviewed
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.